Mutational signatures and clinicopathological relationship extracted from clinical sequence data of 201 caseswith colorectal cancer.
Takeuchi, S., Ling, Y., Watanabe, Y., Shimada, Y., Wakai, T., Okuda, S. Mutational signatures and clinicopathological relationship extracted from clinical sequence data of 201 caseswith colorectal cancer. ASHG2019, Houston (2019/10/16).
SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.
Oyanagi, H., Shimada, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Abe, K., Nakano, M., Kameyama, H., Takii, Y., Kawasaki, T., Homma, K. I., Ling, Y., Okuda, S., Takabe, K., Wakai, T. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer. Histopathology 74(6):873-882 (2019).
Knowledge base toward understanding actionable alterations and realizing precision oncology.
Takeuchi, S., Okuda, S. Knowledge base toward understanding actionable alterations and realizing precision oncology. Int. J. Clin. Oncol. 24(2):123-130 (2019).
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer.
Shimada, Y., Muneoka, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Hirose, Y., Ando, T., Nakano, M., Sakata, J., Kameyama, H., Takii, Y., Ling, Y., Okuda, S., Takabe, K., Wakai, T. BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer. Sci. Rep. 9(1):2466 (2019).
Next generation sequencing-based gene panel tests for the management of solid tumors.
Nagahashi, M., Shimada, Y., Ichikawa, H., Kameyama, H., Takabe, K., Okuda, S., Wakai, T. Next generation sequencing-based gene panel tests for the management of solid tumors. Cancer Sci. 110(1):6-15 (2019).
Novel gene fusions found in cervical cancer.
Ling, Y., Okuda, S. Novel gene fusions found in cervical cancer. EBioMedicine 38:13-14 (2018).
Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions.
Shimada, Y., Tajima, Y., Nagahashi, M., Ichikawa, H., Oyanagi, H., Okuda, S., Takabe, K., Wakai, T. Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions. J. Surg. Res. 232:72-81 (2018).
Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma.
Tamura, R., Nakaoka, H., Yoshihara, K., Mori, Y., Yachida, N., Nishikawa, N., Motoyama, T., Okuda, S., Inoue, I., Enomoto, T. Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosomes Cancer 57(11):557-563 (2018).
Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma.
Nagahashi, M., Sato, S., Yuza, K., Shimada, Y., Ichikawa, H., Watanabe, S., Takada, K., Okamoto, T., Okuda, S., Lyle, S., Takabe, K., Tsuchida, M., Wakai, T. Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma. J. Surg. Res. 230:181-185 (2018).
Pathogenic germline BRCA1/2 mutations and familial predisposition to gastric cancer.
Ichikawa, H., Wakai, T., Nagahashi, M., Shimada, Y., Hanyu, T., Kano, Y., Muneoka, Y., Ishikawa, T., Takizawa, K., Tajima, Y., Sakata, J., Kobayashi, T., Kameyama, H., Yabusaki, H., Nakagawa, S., Sato, N., Kawasaki, T., Homma, K., Okuda, S., Lyle, S., Takabe, K. Pathogenic germline BRCA1/2 mutations and familial predisposition to gastric cancer. JCO Precis. Oncol. 2:PO.18.00097 (2018).